Cepheid this week launched its CE-marked Smart CMV in vitro diagnostic test in Europe for the SmartCycler real-time PCR platform. The test is intended for rapid detection and quantitation of CMV viral load for hospitals, university research labs, and government agencies, the company said. With automation, the SmartCycler system can deliver "highly accurate and consistent test results from prepared biological samples in approximately 30-40 minutes," Cepheid added.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.